Chapter 1 RNAi for Therapeutic Market Overview
1.1 RNAi for Therapeutic Definition
1.2 Global RNAi for Therapeutic Market Size Status and Outlook (2017-2031)
1.3 Global RNAi for Therapeutic Market Size Comparison by Region (2017-2031)
1.4 Global RNAi for Therapeutic Market Size Comparison by Type (2017-2031)
1.5 Global RNAi for Therapeutic Market Size Comparison by Application (2017-2031)
1.6 Global RNAi for Therapeutic Market Size Comparison by Sales Channel (2017-2031)
1.7 RNAi for Therapeutic Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Russia-Ukraine War Impacts
Chapter 2 RNAi for Therapeutic Market Segment Analysis by Player
2.1 Global RNAi for Therapeutic Sales and Market Share by Player (2020-2022)
2.2 Global RNAi for Therapeutic Revenue and Market Share by Player (2020-2022)
2.3 Global RNAi for Therapeutic Average Price by Player (2020-2022)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 RNAi for Therapeutic Market Segment Analysis by Type
3.1 Global RNAi for Therapeutic Market by Type
3.1.1 siRNA
3.1.2 miRNA
3.1.3 shRNA
3.2 Global RNAi for Therapeutic Sales and Market Share by Type (2017-2022)
3.3 Global RNAi for Therapeutic Revenue and Market Share by Type (2017-2022)
3.4 Global RNAi for Therapeutic Average Price by Type (2017-2022)
3.5 Leading Players of RNAi for Therapeutic by Type in 2022
3.6 Conclusion of Segment by Type
Chapter 4 RNAi for Therapeutic Market Segment Analysis by Application
4.1 Global RNAi for Therapeutic Market by Application
4.1.1 Cancer
4.1.2 Cardiovascular
4.1.3 HBV
4.1.4 Other
4.2 Global RNAi for Therapeutic Revenue and Market Share by Application (2017-2022)
4.3 Leading Consumers of RNAi for Therapeutic by Application in 2022
4.4 Conclusion of Segment by Application
Chapter 5 RNAi for Therapeutic Market Segment Analysis by Sales Channel
5.1 Global RNAi for Therapeutic Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global RNAi for Therapeutic Revenue and Market Share by Sales Channel (2017-2022)
5.3 Leading Distributors/Dealers of RNAi for Therapeutic by Sales Channel in 2022
5.4 Conclusion of Segment by Sales Channel
Chapter 6 RNAi for Therapeutic Market Segment Analysis by Region
6.1 Global RNAi for Therapeutic Market Size and CAGR by Region (2017-2031)
6.2 Global RNAi for Therapeutic Sales and Market Share by Region (2017-2022)
6.3 Global RNAi for Therapeutic Revenue and Market Share by Region (2017-2022)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America RNAi for Therapeutic Market Share by Type
6.4.3 North America RNAi for Therapeutic Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe RNAi for Therapeutic Market Share by Type
6.5.3 Europe RNAi for Therapeutic Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific RNAi for Therapeutic Market Share by Type
6.6.3 Asia-Pacific RNAi for Therapeutic Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America RNAi for Therapeutic Market Share by Type
6.7.3 South America RNAi for Therapeutic Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa RNAi for Therapeutic Market Share by Type
6.8.3 Middle East & Africa RNAi for Therapeutic Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading RNAi for Therapeutic Players
7.1 Alnylam Pharmaceuticals
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Arbutus Biopharma (Tekmira)
7.3 Arrowhead
7.4 Dicerna Pharmaceuticals
7.5 Mirna Therapeutics
7.6 Quark Pharmaceuticals
7.7 RXi Pharmaceuticals
7.8 Silence Therapeutics
7.9 Benitec Biopharma
7.10 miRagen Therapeutics
7.11 Sylentis
7.12 Gradalis
7.13 Sirnaomics
7.14 Silenseed
Chapter 8 Upstream and Downstream Analysis of RNAi for Therapeutic
8.1 Industrial Chain of RNAi for Therapeutic
8.2 Upstream of RNAi for Therapeutic
8.3 Downstream of RNAi for Therapeutic
Chapter 9 Development Trend of RNAi for Therapeutic (2023-2031)
9.1 Global RNAi for Therapeutic Market Size (Sales and Revenue) Forecast (2023-2031)
9.2 Global RNAi for Therapeutic Market Size and CAGR Forecast by Region (2023-2031)
9.3 Global RNAi for Therapeutic Market Size and CAGR Forecast by Type (2023-2031)
9.4 Global RNAi for Therapeutic Market Size and CAGR Forecast by Application (2023-2031)
9.5 Global RNAi for Therapeutic Market Size and CAGR Forecast by Sales Channel (2023-2031)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
